Gw Henssler & Associates LTD Abbott Laboratories Transaction History

Gw Henssler & Associates LTD

  • $1.8 Billion
  • Q2 2025

A detailed history of Gw Henssler & Associates LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Gw Henssler & Associates LTD holds 3,796 shares of ABT stock, worth $493,593. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,796
Previous 3,796 -0.0%
Holding current value
$493,593
Previous $503,000 2.58%
% of portfolio
0.03%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$111.1 - $140.22 $119,988 - $151,437
1,080 Added 39.76%
3,796 $503,000
Q1 2025

May 14, 2025
SELL
$111.1 - $140.22 $11,110 - $14,022
-100 Reduced 3.55%
2,716 $360,000
Q1 2024

May 07, 2024
SELL
$109.52 - $120.96 $18,618 - $20,563
-170 Reduced 5.69%
2,816 $320,000
Q4 2023

Jan 26, 2024
BUY
$90.19 - $110.4 $18,849 - $23,073
209 Added 7.53%
2,986 $328,000
Q3 2023

Oct 24, 2023
SELL
$95.53 - $114.62 $34,390 - $41,263
-360 Reduced 11.48%
2,777 $268,000
Q1 2023

Apr 26, 2023
SELL
$96.86 - $114.01 $11,623 - $13,681
-120 Reduced 3.68%
3,137 $317,000
Q4 2022

Feb 03, 2023
SELL
$95.06 - $111.52 $116,543 - $136,723
-1,226 Reduced 27.35%
3,257 $357,000
Q3 2022

Nov 04, 2022
SELL
$96.76 - $112.03 $8,611 - $9,970
-89 Reduced 1.95%
4,483 $434,000
Q2 2022

Aug 04, 2022
SELL
$102.07 - $123.37 $51,035 - $61,685
-500 Reduced 9.86%
4,572 $497,000
Q1 2022

May 09, 2022
SELL
$114.02 - $139.04 $57,010 - $69,520
-500 Reduced 8.97%
5,072 $600,000
Q4 2021

Jan 28, 2022
BUY
$115.53 - $141.46 $643,733 - $788,215
5,572 New
5,572 $784,000
Q3 2021

Nov 02, 2021
SELL
$116.66 - $129.06 $837,035 - $926,005
-7,175 Closed
0 $0
Q2 2021

Aug 09, 2021
SELL
$105.79 - $124.53 $6,876 - $8,094
-65 Reduced 0.9%
7,175 $832,000
Q1 2021

Apr 28, 2021
SELL
$108.84 - $128.23 $19.8 Million - $23.4 Million
-182,157 Reduced 96.18%
7,240 $868,000
Q4 2020

Feb 02, 2021
SELL
$105.0 - $114.42 $306,495 - $333,991
-2,919 Reduced 1.52%
189,397 $20.7 Million
Q3 2020

Oct 22, 2020
SELL
$91.64 - $111.29 $647,986 - $786,931
-7,071 Reduced 3.55%
192,316 $20.9 Million
Q2 2020

Jul 21, 2020
SELL
$76.57 - $98.0 $802,913 - $1.03 Million
-10,486 Reduced 5.0%
199,387 $18.2 Million
Q1 2020

Apr 27, 2020
SELL
$62.82 - $91.86 $700,568 - $1.02 Million
-11,152 Reduced 5.05%
209,873 $16.6 Million
Q4 2019

Feb 24, 2020
SELL
$78.51 - $87.4 $278,553 - $310,095
-3,548 Reduced 1.58%
221,025 $19.2 Million
Q3 2019

Nov 18, 2019
SELL
$81.84 - $88.74 $394,550 - $427,815
-4,821 Reduced 2.1%
224,573 $18.8 Million
Q2 2019

Aug 05, 2019
SELL
$72.88 - $85.0 $601,551 - $701,590
-8,254 Reduced 3.47%
229,394 $19.3 Million
Q1 2019

May 15, 2019
SELL
$66.22 - $80.06 $388,115 - $469,231
-5,861 Reduced 2.41%
237,648 $19 Million
Q4 2018

Jan 22, 2019
SELL
$65.56 - $74.27 $422,599 - $478,744
-6,446 Reduced 2.58%
243,509 $17.6 Million
Q3 2018

Oct 23, 2018
SELL
$60.81 - $73.36 $149,835 - $180,759
-2,464 Reduced 0.98%
249,955 $18.3 Million
Q2 2018

Aug 06, 2018
SELL
$57.57 - $63.54 $3,972 - $4,384
-69 Reduced 0.03%
252,419 $15.4 Million
Q1 2018

May 04, 2018
SELL
$56.27 - $63.62 $220,409 - $249,199
-3,917 Reduced 1.53%
252,488 $15.1 Million
Q4 2017

Feb 06, 2018
BUY
$53.68 - $57.47 $81,378 - $87,124
1,516 Added 0.59%
256,405 $14.6 Million
Q3 2017

Nov 03, 2017
BUY
$48.06 - $53.64 $12.2 Million - $13.7 Million
254,889
254,889 $13.6 Million

Others Institutions Holding ABT

# of Institutions
3,655
Shares Held
1.38B
Call Options Held
10.4M
Put Options Held
9.01M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gw Henssler & Associates LTD Portfolio

Follow Gw Henssler & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw Henssler & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gw Henssler & Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email